Trials / Completed
CompletedNCT00264225
Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis)
A Randomized, Double-Blind, Comparative Parallel Group Study of Analgesic Effectiveness and Safety of Three Different Doses of Lamaline® New Formulation vs Dafalgan® Codeine, After 10 Days Administration in Subjects With Painful Gonarthrosis.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- All
- Age
- 40 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess the analgesic effectiveness and safety of three different doses of a new formulation of Lamaline® versus Dafalgan® Codeine after 10 days administration in subjects with painful gonarthrosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lamaline® , 3 different doses, Dafalgan codeine |
Timeline
- Start date
- 2005-12-01
- First posted
- 2005-12-12
- Last updated
- 2008-02-20
Locations
171 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00264225. Inclusion in this directory is not an endorsement.